Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2024 |
Sep. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|
REVENUES: | ||||
Total revenues | $ 1,029,630 | $ 720,450 | $ 2,559,008 | $ 2,181,091 |
OPERATING EXPENSES: | ||||
Compensation and benefits | 259,268 | 345,907 | 798,447 | 1,055,284 |
Professional fees | 65,291 | 86,152 | 276,426 | 288,735 |
Brokerage fees | 19,033 | 122,363 | 50,571 | |
General and administrative expenses | 84,613 | 95,716 | 262,977 | 274,283 |
Depreciation and amortization | 89,701 | 91,224 | 269,218 | 290,854 |
Real estate taxes | 49,536 | 52,339 | 112,467 | 115,833 |
Property portfolio business development costs | 17,000 | 39,875 | 15,000 | |
Total operating expenses, net | 584,442 | 671,338 | 1,881,773 | 2,090,560 |
INCOME FROM OPERATIONS | 445,188 | 49,112 | 677,235 | 90,531 |
OTHER INCOME (EXPENSES): | ||||
Interest expenses | (187,167) | (155,376) | (501,670) | (466,866) |
Income (loss) from derivative - interest rate swap | (199,149) | 220,787 | (52,503) | 230,479 |
Total other income (expenses), net | (386,316) | 65,411 | (554,173) | (236,387) |
INCOME (LOSS) BEFORE EQUITY METHOD LOSSES | 58,872 | 114,523 | 123,062 | (145,856) |
EQUITY METHOD LOSS: | ||||
Equity method loss from unconsolidated joint ventures | (7,110) | |||
Total equity method loss | (7,110) | |||
Net income (loss) | $ 58,872 | $ 114,523 | $ 123,062 | $ (152,966) |
NET INCOME (LOSS) PER COMMON SHARE: | ||||
Basic (in Dollars per share) | $ 0 | $ 0.01 | $ 0.01 | $ (0.01) |
Diluted (in Dollars per share) | $ 0 | $ 0.01 | $ 0.01 | $ (0.01) |
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: | ||||
Basic (in Shares) | 12,101,062 | 12,201,548 | 12,101,385 | 12,201,548 |
Diluted (in Shares) | 12,501,062 | 12,601,548 | 12,501,385 | 12,201,548 |
Property investment portfolio revenues | ||||
REVENUES: | ||||
Total revenues | $ 750,926 | $ 637,143 | $ 2,121,544 | $ 1,857,208 |
Real estate services revenues | ||||
REVENUES: | ||||
Total revenues | $ 278,704 | $ 83,307 | $ 437,464 | $ 323,883 |
X | ||||||||||
- Definition Business development involves the development of products and services, their delivery, design and their implementation. Business development includes a number of techniques designed to grow an economic enterprise. Such techniques include, but are not limited to, assessments of marketing opportunities and target markets, intelligence gathering on customers and competitors, generating leads for possible sales, follow-up sales activity, formal proposal writing and business model design. Business development involves evaluating a business and then realizing its full potential, using such tools as marketing, sales, information management and customer service. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of expenses related to the generation of investment income. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition A tax based on the assessed value of real estate by the local government. The tax is usually based on the value of property (including the land). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of brokerage fees. No definition available.
|
X | ||||||||||
- Definition Amount of equity method loss from unconsolidated joint ventures. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|